PURE Bioscience, Inc. (PURE)

PURE Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 17, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Market Capitalization	6	10	9	10	22	37
Market Cap Growth	-16.92%	12.56%	-6.12%	-57.25%	-39.30%	-70.52%
Enterprise Value	12	14	11	9	22	34
Last Close Price	0.06	0.09	0.08	0.09	0.20	0.42
PS Ratio	2.66	4.56	4.55	5.07	12.00	9.33
PB Ratio	-1.13	-1.96	-3.12	34.96	5.69	10.99
P/TBV Ratio	-	-	-	34.96	5.69	12.35
EV/Sales Ratio	4.89	6.54	5.55	4.65	11.73	8.67
Debt / Equity Ratio	-1.02	-1.02	-1.03	3.75	-	0.07
Net Debt / Equity Ratio	-0.94	-0.96	-0.91	-0.27	-0.87	-0.64
Net Debt / EBITDA Ratio	-2.55	-2.16	-0.87	0.02	1.07	1.01
Net Debt / FCF Ratio	-2.98	-2.43	-1.03	0.02	1.36	1.27
Asset Turnover	2.23	2.35	1.49	0.60	0.42	0.74
Inventory Turnover	5.99	9.13	11.26	6.79	3.34	4.21
Quick Ratio	0.26	0.86	0.88	2.59	6.25	2.84
Current Ratio	0.37	1.12	1.10	3.02	6.72	3.30
Return on Equity (ROE)	-	-	-	-189.48%	-96.41%	-56.95%
Return on Assets (ROA)	-119.91%	-151.39%	-148.08%	-71.88%	-47.94%	-27.19%
Return on Capital Employed (ROCE)	102.60%	-1893.30%	-3683.50%	-280.60%	-86.20%	-69.30%
Earnings Yield	-34.70%	-23.88%	-37.53%	-41.66%	-15.70%	-6.33%
FCF Yield	-	-20.05%	-28.36%	-34.82%	-11.24%	-4.61%
Buyback Yield / Dilution	-0.01%	-0.01%	-0.41%	-25.41%	-1.91%	-3.03%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.